Results 21 to 30 of about 172,233 (314)

Anticoagulants [PDF]

Journal of Pharmacy and Pharmacology, 1949
Abstract The processes that underly the clotting of blood are still far from adequately understood, in spite of the many facts uncovered by generations of patient investigators. The classical scheme associated with the name of Morawitz1, although neither complete nor universally accepted, is still useful as a summary of the main events ...
openaire   +2 more sources

Impact of anticoagulation and antiplatelet therapy on dialysis catheter fibrin sheath formation [PDF]

, 2022
PURPOSEFibrin sheaths are a significant cause of dialysis catheter dysfunction. This study aimed to determine the role of anticoagulation, antiplatelet medications, and other factors in delaying fibrin sheath formation.METHODSAn institutional review ...
Forrest B. Linch, Mauricio F. Jin, Richard G. Frimpong, Scott M. Thompson, Christopher J. Reisenauer, Edwin A. Takahashi   +5 more
core   +1 more source

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry

Thrombosis Journal, 2020
Background For the improvement of AF care, it is important to gain insight into current anticoagulation prescription practices and guideline adherence. This report focuses on the largest Dutch subset of AF-patients, derived from the GARFIELD-AF registry.
J. Seelig, F. W. A. Verheugt, M. E. W. Hemels, L. Illingworth, A. Lucassen, H. Adriaansen, M. C. M. Bongaerts, M. Pieterse, J. P. R. Herrman, P. Hoogslag, W. Hermans, B. E. Groenemeijer, L. V. A. Boersma, K. Pieper, H. ten Cate, on behalf of the GARFIELD-AF Investigators   +15 more
doaj   +1 more source

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review

Pharmacy, 2016
The purpose of this article is to report a case of fondaparinux outpatient utilization for anticoagulation in a patient with a past medical history of heparin-induced thrombocytopenia (HIT) and discuss the options and need for future anticoagulation ...
Amy Christopher
doaj   +1 more source

Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies

TH Open, 2022
Background Thromboembolism remains a detrimental complication of novel coronavirus disease (COVID-19) despite the use of prophylactic doses of anticoagulation Objectives This study aimed to compare different thromboprophylaxis strategies in ...
Maha A. T. Elsebaie, Binav Baral, Mai Elsebaie, Trilok Shrivastava, Catherine Weir, Dennis Kumi, Noah W. Birch   +6 more
doaj   +1 more source

Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation

, 2015
Background: Center-specific TTR (c-TTR) is a measure reporting the mean patient TTR within an anticoagulation clinic describing the quality of anticoagulant monitoring offered by that clinic.
Manotti C, Tosetto A, Italian Federation of Anticoagulation Clinics (FCSA) clinical quality study group, Serino Maria Luisa, Marongiu F   +4 more
core   +2 more sources

Pharmacogenetics of Anticoagulants [PDF]

Human Genomics and Proteomics, 2010
Warfarin, acenocoumarol, and phenprocoumon are among the major anticoagulant drugs worldwide. Because of their low therapeutic index and serious adverse reactions (ADRs), their wide use, and their varying kinetics and pharmacogenetic dependence, it is of great importance to explore further possibilities to forecast the dose beyond conventional INR ...
Rane, Anders, Lindh, Jonatan D.
openaire   +2 more sources

Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC

, 2011
Background: Oral anticoagulant therapy (OAT) with warfarin is the standard of stroke prevention in patients with atrial fibrillation. Approximately 30% of patients with cardioembolic strokes are on OAT at the time of symptom onset.
Förch, Christian, Waltraud Pfeilschifter, Daniel Spitzer, Pfeilschifter, Josef (Prof. Dr.), Helmuth Steinmetz, Spitzer, Daniel, Steinmetz, Helmuth, Steinmetz Helmuth, Christian Foerch, Pfeilschifter, Waltraud, Josef Pfeilschifter, Pfeilschifter Waltraud, Spitzer Daniel, Foerch Christian, Pfeilschifter Josef   +14 more
core   +1 more source

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis

Frontiers in Pharmacology, 2023
Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial.
Qiang Zhou, Xiang Liu, Xian Yang, Xiao-Hui Huang, Yan-Zi Wu, Ying-Ying Tao, Meng Wei   +6 more
doaj   +1 more source

Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases

, 2013
We present the case of an aphasic 77-year-old stroke patient with left distal M1 occlusion who received rt-PA for thrombolysis while on oral anticoagulant treatment with dabigatran (150 mg b.i.d.).
Baas, Horst, Mario Abruscato, Susanne Hövelmann, Pfeilschifter, Waltraud, Abruscato, Mario Giovanni Rosario, Hövelmann, Susanne, Horst Baas, Waltraud Pfeilschifter   +7 more
core   +1 more source